ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.

Jeong, H M; Han, J; Lee, S H; Park, H-J; Lee, H J; Choi, J-S; Lee, Y M; Choi, Y-L; Shin, Y K; Kwon, M J.

Afiliação

Jeong HM; Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy, Seoul National University, Seoul, Korea.
Han J; Gencurix Inc., 242 Digital-ro, Seoul, Korea.
Lee SH; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Korea.
Park HJ; The Center for Anti-cancer Companion Diagnostics, Bio-MAX/N-Bio, Seoul National University, Seoul, Korea.
Lee HJ; Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Korea.
Choi JS; The Center for Anti-cancer Companion Diagnostics, Bio-MAX/N-Bio, Seoul National University, Seoul, Korea.
Lee YM; BK21 Plus KNU Multi-Omics based Creative Drug Research Team, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Kyungpook National University, Daegu, Korea.
Choi YL; Laboratory of Cancer Genomics and Molecular Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shin YK; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kwon MJ; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.

Oncogenesis ; 6(10): e389, 2017 Oct 09.

Article em En | MEDLINE | ID: mdl-28991261

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article